Migraine Treatment Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Migraine Treatment Market?

The migraine treatment market has experienced significant growth in recent years. It is forecast to grow from $3.18 billion in 2024 to $3.45 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.4%. This historical growth can be attributed to several factors including the rising prevalence of migraines, increased healthcare spending, enhancements in existing drug formulations, the expansion of clinical research, and the introduction of novel therapies.

The migraine treatment market size is anticipated to undergo significant expansion over the next few years, projected to reach $5.21 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 10.9%. This projected growth during the forecast period is driven by various factors, including heightened awareness and education, the introduction of monoclonal antibodies, an increased focus on pediatric migraines, the broadening of non-pharmacological interventions, and worldwide initiatives for migraine research. Prominent trends expected in this period encompass progress in therapeutic approaches, the rise of wearable devices and digital therapeutics, the increasing use of telemedicine and remote consultations, the adoption of patient-centric care models, the expansion of the generic drug market, and the development of oral CGRP inhibitors.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

Which Factors And Drivers Are Influencing The Migraine Treatment Market In 2025?

Extended screen exposure is anticipated to fuel the expansion of the migraine treatment market. This term denotes the duration individuals spend engaging with electronic displays found on devices like smartphones, tablets, computers, and televisions. Factors such as a rise in remote work, online learning, digital entertainment, and increased dependence on technology for social connections contribute to this prolonged screen time. Migraine treatment specifically addresses symptoms of migraine that are initiated or exacerbated by extensive screen use, encompassing pharmaceutical interventions, adjustments to lifestyle, and ergonomic practices aimed at reducing strain and preventing episodes. As an illustration, in May 2024, the House of Commons Committee, a UK-based Parliament health agency, reported that children’s screen time in 2021 had surged by 52% in 2022, with almost 25% of children and young people exhibiting smartphone usage behaviors akin to behavioral addiction. Consequently, the prolonged screen exposure is acting as a catalyst for growth in the migraine treatment market.

What Are The Key Segments In The Migraine Treatment Market?

The migraine treatmentmarket covered in this report is segmented –

1) By Types: Episodic; Migraine With Aura; Chronic; Other Types

2) By Treatment: Acute Or Abortive Treatment; Preventive Or prophylactic Treatment; Non-Pharmacological Therapies And Devices

3) By End-User: Hospitals; Clinics; Homecare; Other End-users

Subsegments:

1) By Episodic: Frequent Episodic Migraine; Infrequent Episodic Migraine

2) By Migraine With Aura: Visual Aura; Sensory Aura; Speech Or Language Aura

3) By Chronic: Chronic Migraine Without Aura; Chronic Migraine With Aura

4) By Other Types: Hemiplegic Migraine; Retinal Migraine; Menstrual Migraine; Other Specific Types

Which Key Trends Are Expected To Influence The Migraine Treatment Market In The Coming Years?

Product innovations represent a key trend gaining popularity within the migraine treatment market. Major companies operating in the market are introducing advancements such as liquid formulations to sustain their position. For instance, in January 2022, BioDelivery Sciences International (BDSI), a US-based pharmaceutical company, released Elyxyb (celecoxib oral solution), an acute treatment for migraines in adults, applicable whether or not they experience aura. Its liquid formulation enables rapid absorption in the small intestine, providing faster relief compared to conventional tablets. This is particularly advantageous for migraine sufferers who experience nausea or vomiting, as it removes the requirement to wait for a pill to dissolve. As the first and only FDA-approved ready-to-use oral solution for migraines, Elyxyb offers a more tolerable and efficient treatment alternative for managing the sudden, intense pain linked with migraines.

Who Are The Prominent Global Companies Shaping The Migraine Treatment Market?

Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

How Does The Migraine Treatment Market Perform Across Key Geographic Regions?

North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Migraine Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp

Browse Through More Reports Similar to the Global Migraine Treatment Market 2025, By The Business Research Company

Ent Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report

Nasal Splints Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nasal-splints-global-market-report

Cough And Cold Preparations Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795